Short answer
PRO DEX INC (PDEX) filed its Q1 2026 10-Q quarterly report on Apr 30, 2026 for the quarter ended Mar 31, 2026. Quarterly revenue was $20M (up 14.6% year over year) with net income of $4M.
Q1 2026 key financials · XBRL
- Revenue
- $20M
- +14.6% YoY · +6.9% QoQ
- Net income
- $4M
- +20.2% YoY · +80.1% QoQ
- Operating margin
- 15.5%
- Gross margin
- 30.7%
- EPS (diluted)
- $1.20
- +22.4% YoY · +79.1% QoQ
Source: XBRL data from the PRO DEX INC (PDEX) Q1 2026 10-Q on SEC EDGAR. USD.
PRO DEX INC Q1 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $19.949M, up 15% YoY from $17.414M
- Gross margin 31% vs 33% YoY, down 2 percentage points
- Best line medical devices $16.242M, up 36%; orthopedic $13.073M, up 52%
- Worst line repairs $2.673M, down 48% from $5.099M
- Cash $10.0M vs $419,000 at June 30; operating cash flow $7.515M vs $(1.509)M
- APM acquisition $6.5M; share repurchases $2.8M; backlog $39.0M with $15.6M due in fourth quarter
- Outlook: orthopedic revenue expected at similar levels through 2028; repair revenue may continue declining
Risk Factors
- No material changes to risk factors from the June 30, 2025 Form 10-K
- Acquisition of Advanced-Precision Machining introduced transaction-related execution risk on February 9, 2026
- Amended credit agreement and new Term Note D increased financing and covenant exposure on February 9, 2026
- CEO trading arrangement covers disposition of up to 10,000 shares beginning May 21, 2026
- Chairman’s trading arrangement covers disposition of up to $3.0 million of common stock beginning June 22, 2026
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other PRO DEX INC quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.